News

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...
HealthDay on MSN14h
FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines
Key Takeaways Federal regulators have issued a warning about rare heart inflammation in young males after mRNA COVID ...
India Today on MSN5h
Covid-19 vaccine rules may change from 2025: What you should know
The FDA may limit annual COVID-19 boosters to high-risk groups unless clinical trials prove benefits for healthy adults under ...
STAT4h
FDA gives Covid vaccine manufacturers instructions for next fall’s shot
The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...
Trump’s FDA just changed COVID vaccine rules for 2025 — will you still qualify for boosters under the new guidelines?
FDA COVID vaccine update is stirring major public attention as a new policy limits fall COVID-19 booster shots to seniors and ...
WUSF Public Media4h
Vaccine advisers to the FDA recommended changes to COVID vaccines
Advisers to the Food and Drug Administration met Thursday to help decide which variant of the virus that causes COVID should ...
Healio9h
FDA tells vaccine makers to expand warning labels on COVID-19 shots
The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the ...
GOP Senate report finds Biden health officials misled public about risks of myocarditis from COVID-19 vaccines
The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
MedPage Today7h
FDA Panel Recommends Monovalent COVID Vaccine for Next Season
An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...
With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...
ZAWYA1h
COVID shots should target newer strains of JN.1 variant, US FDA advisers say
U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period should target newer strains of the JN.1 variant. COVID vaccine makers are ...